Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NIACIN ER 500 MG TABLET

NIACIN
$0.1602per EA

Strength

500 mg/1

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

47335053981

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NIACIN

Approval Type

Generic (ANDA)

FDA Application

ANDA200484

On Market Since

6/27/2014

Pharmacological Classes

Nicotinic Acid
Nicotinic Acids

Price History

1W

0.0%

1M

-3.7%

3M

-2.6%

6M

-0.7%

1Y

-5.2%

3Y

-24.3%

5Y

-34.0%

All

-94.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MULTIVIT-FLUOR 0.5 MG TAB CHEW
Generic
58657016401•Method Pharmaceuticals LLC
$0.0969
per EA
MULTIVIT-FLUOR 0.5 MG TAB CHEW
Generic
58657016490•Method Pharmaceuticals LLC
$0.0969
per EA
MULTIVIT-FLUORIDE 1 MG TAB CHW
Generic
58657016501•Method Pharmaceuticals LLC
$0.0969
per EA
MULTIVIT-FLUORIDE 1 MG TAB CHW
Generic
58657016590•Method Pharmaceuticals LLC
$0.0969
per EA
MULTIVIT-FLUOR 0.25 MG TAB CHW
Generic
58657016301•Method Pharmaceuticals LLC
$0.1035
per EA
MULTIVIT-FLUOR 0.25 MG TAB CHW
Generic
58657016390•Method Pharmaceuticals LLC
$0.1035
per EA
M-NATAL PLUS TABLET
Generic
58657017001•Method Pharmaceuticals LLC
$0.1051
per EA
NIACIN ER 500 MG TABLET
Generic
33342018710•Macleods Pharmaceuticals Limited
$0.1602
per EA
NIACIN ER 500 MG TABLET
Generic
50268058413•AvPAK
$0.1602
per EA
NIACIN ER 500 MG TABLET
Generic
59651001818•Aurobindo Pharma Limited
$0.1602
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy